|18.40||-21.10 / -53.42%|
As of 4:00pm ET
|19.20||+0.80 / +4.35%|
The 1 analysts offering 12-month price forecasts for KaloBios Pharmaceuticals Inc have a median target of 64.00, with a high estimate of 64.00 and a low estimate of 64.00. The median estimate represents a +247.83% increase from the last price of 18.40.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.